カテゴリー： QYResearch, 世界

世界の腋窩多汗症薬市場 2019年

【英語タイトル】Global Axillary Hyperhidrosis Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X04295）・商品コード：DATA909X04295
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、腋窩多汗症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ボツリヌストキシンA、グリコピロレート、グリコピロニウムトシレート、その他に、用途別には、クリニック、病院、ホームケアにセグメント区分し、腋窩多汗症薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・腋窩多汗症薬の世界市場概要
・腋窩多汗症薬の製造コスト構成分析
・腋窩多汗症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・腋窩多汗症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・腋窩多汗症薬のセグメント分析（種類別）
（ボツリヌストキシンA、グリコピロレート、グリコピロニウムトシレート、その他）
・腋窩多汗症薬のセグメント分析（用途別）
（クリニック、病院、ホームケア）
・腋窩多汗症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Allergan Plc、Brickell Biotech Inc、Dermira Inc、Dr. August Wolff GmbH & Co KG Arzneimittle、GlaxoSmithKline Plc、TheraVida Inc、）
・腋窩多汗症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Axillary Hyperhidrosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Axillary Hyperhidrosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Axillary Hyperhidrosis Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Axillary Hyperhidrosis Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Axillary Hyperhidrosis Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Allergan Plc
Brickell Biotech Inc
Dermira Inc
Dr. August Wolff GmbH & Co KG Arzneimittle
GlaxoSmithKline Plc
TheraVida Inc
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Botulinum ToxinA
Glycopyrrolate
Glycopyrronium Tosylate
Others

Segment by Application
Clinic
Hospital
Home Care

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Axillary Hyperhidrosis Drug
1.1 Definition of Axillary Hyperhidrosis Drug
1.2 Axillary Hyperhidrosis Drug Segment by Type
1.2.1 Global Axillary Hyperhidrosis Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Botulinum ToxinA
1.2.3 Glycopyrrolate
1.2.4 Glycopyrronium Tosylate
1.2.5 Others
1.3 Axillary Hyperhidrosis Drug Segment by Applications
1.3.1 Global Axillary Hyperhidrosis Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Care
1.4 Global Axillary Hyperhidrosis Drug Overall Market
1.4.1 Global Axillary Hyperhidrosis Drug Revenue (2014-2025)
1.4.2 Global Axillary Hyperhidrosis Drug Production (2014-2025)
1.4.3 North America Axillary Hyperhidrosis Drug Status and Prospect (2014-2025)
1.4.4 Europe Axillary Hyperhidrosis Drug Status and Prospect (2014-2025)
1.4.5 China Axillary Hyperhidrosis Drug Status and Prospect (2014-2025)
1.4.6 Japan Axillary Hyperhidrosis Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Axillary Hyperhidrosis Drug Status and Prospect (2014-2025)
1.4.8 India Axillary Hyperhidrosis Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Axillary Hyperhidrosis Drug
2.3 Manufacturing Process Analysis of Axillary Hyperhidrosis Drug
2.4 Industry Chain Structure of Axillary Hyperhidrosis Drug

3 Development and Manufacturing Plants Analysis of Axillary Hyperhidrosis Drug
3.1 Capacity and Commercial Production Date
3.2 Global Axillary Hyperhidrosis Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Axillary Hyperhidrosis Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Axillary Hyperhidrosis Drug Production and Capacity Analysis
4.2 Axillary Hyperhidrosis Drug Revenue Analysis
4.3 Axillary Hyperhidrosis Drug Price Analysis
4.4 Market Concentration Degree

5 Axillary Hyperhidrosis Drug Regional Market Analysis
5.1 Axillary Hyperhidrosis Drug Production by Regions
5.1.1 Global Axillary Hyperhidrosis Drug Production by Regions
5.1.2 Global Axillary Hyperhidrosis Drug Revenue by Regions
5.2 Axillary Hyperhidrosis Drug Consumption by Regions
5.3 North America Axillary Hyperhidrosis Drug Market Analysis
5.3.1 North America Axillary Hyperhidrosis Drug Production
5.3.2 North America Axillary Hyperhidrosis Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Axillary Hyperhidrosis Drug Import and Export
5.4 Europe Axillary Hyperhidrosis Drug Market Analysis
5.4.1 Europe Axillary Hyperhidrosis Drug Production
5.4.2 Europe Axillary Hyperhidrosis Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Axillary Hyperhidrosis Drug Import and Export
5.5 China Axillary Hyperhidrosis Drug Market Analysis
5.5.1 China Axillary Hyperhidrosis Drug Production
5.5.2 China Axillary Hyperhidrosis Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Axillary Hyperhidrosis Drug Import and Export
5.6 Japan Axillary Hyperhidrosis Drug Market Analysis
5.6.1 Japan Axillary Hyperhidrosis Drug Production
5.6.2 Japan Axillary Hyperhidrosis Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Axillary Hyperhidrosis Drug Import and Export
5.7 Southeast Asia Axillary Hyperhidrosis Drug Market Analysis
5.7.1 Southeast Asia Axillary Hyperhidrosis Drug Production
5.7.2 Southeast Asia Axillary Hyperhidrosis Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Axillary Hyperhidrosis Drug Import and Export
5.8 India Axillary Hyperhidrosis Drug Market Analysis
5.8.1 India Axillary Hyperhidrosis Drug Production
5.8.2 India Axillary Hyperhidrosis Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Axillary Hyperhidrosis Drug Import and Export

6 Axillary Hyperhidrosis Drug Segment Market Analysis (by Type)
6.1 Global Axillary Hyperhidrosis Drug Production by Type
6.2 Global Axillary Hyperhidrosis Drug Revenue by Type
6.3 Axillary Hyperhidrosis Drug Price by Type

7 Axillary Hyperhidrosis Drug Segment Market Analysis (by Application)
7.1 Global Axillary Hyperhidrosis Drug Consumption by Application
7.2 Global Axillary Hyperhidrosis Drug Consumption Market Share by Application (2014-2019)

8 Axillary Hyperhidrosis Drug Major Manufacturers Analysis
8.1 Allergan Plc
8.1.1 Allergan Plc Axillary Hyperhidrosis Drug Production Sites and Area Served
8.1.2 Allergan Plc Product Introduction, Application and Specification
8.1.3 Allergan Plc Axillary Hyperhidrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Brickell Biotech Inc
8.2.1 Brickell Biotech Inc Axillary Hyperhidrosis Drug Production Sites and Area Served
8.2.2 Brickell Biotech Inc Product Introduction, Application and Specification
8.2.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Dermira Inc
8.3.1 Dermira Inc Axillary Hyperhidrosis Drug Production Sites and Area Served
8.3.2 Dermira Inc Product Introduction, Application and Specification
8.3.3 Dermira Inc Axillary Hyperhidrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Dr. August Wolff GmbH & Co KG Arzneimittle
8.4.1 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Production Sites and Area Served
8.4.2 Dr. August Wolff GmbH & Co KG Arzneimittle Product Introduction, Application and Specification
8.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 GlaxoSmithKline Plc
8.5.1 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Production Sites and Area Served
8.5.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.5.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 TheraVida Inc
8.6.1 TheraVida Inc Axillary Hyperhidrosis Drug Production Sites and Area Served
8.6.2 TheraVida Inc Product Introduction, Application and Specification
8.6.3 TheraVida Inc Axillary Hyperhidrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served

9 Development Trend of Analysis of Axillary Hyperhidrosis Drug Market
9.1 Global Axillary Hyperhidrosis Drug Market Trend Analysis
9.1.1 Global Axillary Hyperhidrosis Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Axillary Hyperhidrosis Drug Regional Market Trend
9.2.1 North America Axillary Hyperhidrosis Drug Forecast 2019-2025
9.2.2 Europe Axillary Hyperhidrosis Drug Forecast 2019-2025
9.2.3 China Axillary Hyperhidrosis Drug Forecast 2019-2025
9.2.4 Japan Axillary Hyperhidrosis Drug Forecast 2019-2025
9.2.5 Southeast Asia Axillary Hyperhidrosis Drug Forecast 2019-2025
9.2.6 India Axillary Hyperhidrosis Drug Forecast 2019-2025
9.3 Axillary Hyperhidrosis Drug Market Trend (Product Type)
9.4 Axillary Hyperhidrosis Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Axillary Hyperhidrosis Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Axillary Hyperhidrosis Drug
Table Global Axillary Hyperhidrosis Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Axillary Hyperhidrosis Drug Production Market Share by Types in 2018
Figure Botulinum ToxinA Product Picture
Figure Glycopyrrolate Product Picture
Figure Glycopyrronium Tosylate Product Picture
Figure Others Product Picture
Table Global Axillary Hyperhidrosis Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Axillary Hyperhidrosis Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Home Care
Figure Global Axillary Hyperhidrosis Drug Revenue (Million USD) (2014-2025)
Figure Global Axillary Hyperhidrosis Drug Production (K Pcs) (2014-2025)
Figure North America Axillary Hyperhidrosis Drug Market Size (Million USD) (2014-2025)
Figure Europe Axillary Hyperhidrosis Drug Market Size (Million USD) (2014-2025)
Figure China Axillary Hyperhidrosis Drug Market Size (Million USD) (2014-2025)
Figure Japan Axillary Hyperhidrosis Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Axillary Hyperhidrosis Drug Market Size (Million USD) (2014-2025)
Figure India Axillary Hyperhidrosis Drug Market Size (Million USD) (2014-2025)
Table Axillary Hyperhidrosis Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Axillary Hyperhidrosis Drug in 2018
Figure Manufacturing Process Analysis of Axillary Hyperhidrosis Drug
Figure Industry Chain Structure of Axillary Hyperhidrosis Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Axillary Hyperhidrosis Drug Manufacturing Plants Distribution
Table Axillary Hyperhidrosis Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Axillary Hyperhidrosis Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Axillary Hyperhidrosis Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Axillary Hyperhidrosis Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Axillary Hyperhidrosis Drug Production Share by Manufacturers in 2018
Table Axillary Hyperhidrosis Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Axillary Hyperhidrosis Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Axillary Hyperhidrosis Drug Revenue Share by Manufacturers in 2018
Table Axillary Hyperhidrosis Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Axillary Hyperhidrosis Drug Production by Regions 2014-2019 (K Pcs)
Table Global Axillary Hyperhidrosis Drug Production Market Share by Regions 2014-2019
Figure Global Axillary Hyperhidrosis Drug Production Market Share by Regions in 2018
Table Global Axillary Hyperhidrosis Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Axillary Hyperhidrosis Drug Revenue Market Share by Regions 2014-2019
Figure Global Axillary Hyperhidrosis Drug Revenue Market Share by Regions in 2018
Table Global Axillary Hyperhidrosis Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Axillary Hyperhidrosis Drug Consumption Market Share by Regions 2014-2019
Figure North America Axillary Hyperhidrosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Axillary Hyperhidrosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Axillary Hyperhidrosis Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Axillary Hyperhidrosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Axillary Hyperhidrosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Axillary Hyperhidrosis Drug Production, Consumption Import and Export (K Pcs)
Figure China Axillary Hyperhidrosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Axillary Hyperhidrosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Axillary Hyperhidrosis Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Axillary Hyperhidrosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Axillary Hyperhidrosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Axillary Hyperhidrosis Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Axillary Hyperhidrosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Axillary Hyperhidrosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Axillary Hyperhidrosis Drug Production, Consumption Import and Export (K Pcs)
Figure India Axillary Hyperhidrosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Axillary Hyperhidrosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Axillary Hyperhidrosis Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Axillary Hyperhidrosis Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Axillary Hyperhidrosis Drug Market Share by Application (2014-2019)
Table Allergan Plc Axillary Hyperhidrosis Drug Production Sites and Area Served
Table Allergan Plc Axillary Hyperhidrosis Drug Product Introduction, Application and Specification
Table Allergan Plc Axillary Hyperhidrosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Allergan Plc Axillary Hyperhidrosis Drug Production Growth Rate (2014-2019)
Table Allergan Plc Axillary Hyperhidrosis Drug Production Market Share (2014-2019)
Figure Allergan Plc Axillary Hyperhidrosis Drug Revenue Market Share (2014-2019)
Table Allergan Plc Axillary Hyperhidrosis Drug Main Business and Markets Served
Table Brickell Biotech Inc Axillary Hyperhidrosis Drug Production Sites and Area Served
Table Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Introduction, Application and Specification
Table Brickell Biotech Inc Axillary Hyperhidrosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Brickell Biotech Inc Axillary Hyperhidrosis Drug Production Growth Rate (2014-2019)
Table Brickell Biotech Inc Axillary Hyperhidrosis Drug Production Market Share (2014-2019)
Figure Brickell Biotech Inc Axillary Hyperhidrosis Drug Revenue Market Share (2014-2019)
Table Brickell Biotech Inc Axillary Hyperhidrosis Drug Main Business and Markets Served
Table Dermira Inc Axillary Hyperhidrosis Drug Production Sites and Area Served
Table Dermira Inc Axillary Hyperhidrosis Drug Product Introduction, Application and Specification
Table Dermira Inc Axillary Hyperhidrosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Dermira Inc Axillary Hyperhidrosis Drug Production Growth Rate (2014-2019)
Table Dermira Inc Axillary Hyperhidrosis Drug Production Market Share (2014-2019)
Figure Dermira Inc Axillary Hyperhidrosis Drug Revenue Market Share (2014-2019)
Table Dermira Inc Axillary Hyperhidrosis Drug Main Business and Markets Served
Table Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Production Sites and Area Served
Table Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Introduction, Application and Specification
Table Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Production Growth Rate (2014-2019)
Table Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Production Market Share (2014-2019)
Figure Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Revenue Market Share (2014-2019)
Table Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Main Business and Markets Served
Table GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Production Sites and Area Served
Table GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Main Business and Markets Served
Table TheraVida Inc Axillary Hyperhidrosis Drug Production Sites and Area Served
Table TheraVida Inc Axillary Hyperhidrosis Drug Product Introduction, Application and Specification
Table TheraVida Inc Axillary Hyperhidrosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table TheraVida Inc Axillary Hyperhidrosis Drug Production Growth Rate (2014-2019)
Table TheraVida Inc Axillary Hyperhidrosis Drug Production Market Share (2014-2019)
Figure TheraVida Inc Axillary Hyperhidrosis Drug Revenue Market Share (2014-2019)
Table TheraVida Inc Axillary Hyperhidrosis Drug Main Business and Markets Served
Figure Global Axillary Hyperhidrosis Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Axillary Hyperhidrosis Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Axillary Hyperhidrosis Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Axillary Hyperhidrosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Axillary Hyperhidrosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Axillary Hyperhidrosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Axillary Hyperhidrosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Axillary Hyperhidrosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Axillary Hyperhidrosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Axillary Hyperhidrosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Axillary Hyperhidrosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Axillary Hyperhidrosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Axillary Hyperhidrosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Axillary Hyperhidrosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Axillary Hyperhidrosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Axillary Hyperhidrosis Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Axillary Hyperhidrosis Drug by Application (2019-2025)
Table Axillary Hyperhidrosis Drug Distributors List
Table Axillary Hyperhidrosis Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Allergan Plc、Brickell Biotech Inc、Dermira Inc、Dr. August Wolff GmbH & Co KG Arzneimittle、GlaxoSmithKline Plc、TheraVida Inc、

★調査レポート[世界の腋窩多汗症薬市場 2019年] (コード：DATA909X04295)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の腋窩多汗症薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の多汗症におけるエネルギーベース装置市場 2019年
    DATA909X07329 / QYResearch / 2019年11月15日 / ※本調査レポートは、多汗症におけるエネルギーベース装置の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、レーザー装置、マイクロ波装置、超音波装置に、用途別には、病院及びクリニック、美容室にセグメント区分し、多汗症におけるエネルギーベース装置の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多汗症におけるエネルギーベース装置の世界市場概要 ・多汗症におけるエネルギーベース装置の製造コスト構成分析 ・多汗症におけるエネルギーベース装置の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多汗症におけるエネルギーベース装置の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多汗症におけるエネルギーベース装置のセグメント分析（種類別） （レーザー装置、マイクロ波装置、超音波装置）...The global Energy Based Device in Hyperhidrosis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Energy Based Device in Hyperhidrosis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Energy Based Device in Hyperhidrosis market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Energy Based Device in Hyperhidrosis in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の甲状腺機能低下症薬市場 2019年
    DATA909X09522 / QYResearch / 2019年11月20日 / ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他に、用途別には、病院、診療所、その他にセグメント区分し、甲状腺機能低下症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺機能低下症薬の世界市場概要 ・甲状腺機能低下症薬の製造コスト構成分析 ・甲状腺機能低下症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺機能低下症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺機能低下症薬のセグメント分析（種類別） （BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）...The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypothyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypothyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypothyroidism Drug manufacturing...
  • 世界のコクシジオイデス症薬剤市場 2019年
    DATA909X05597 / QYResearch / 2019年11月15日 / ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、コクシジオイデス症薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・コクシジオイデス症薬剤の世界市場概要 ・コクシジオイデス症薬剤の製造コスト構成分析 ・コクシジオイデス症薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・コクシジオイデス症薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・コクシジオイデス症薬剤のセグメント分析（種類別） （VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）...The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coccidioidomycosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coccidioidomycosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Coccidioidomycosis Drug manufacturing...
  • 世界のファンコニ貧血薬市場 2019年
    DATA909X07597 / QYResearch / 2019年11月15日 / ※本調査レポートは、ファンコニ貧血薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エルトロンボパグオラミン、EXG-34217、ファンカレン、その他に、用途別には、病院、診療所、その他にセグメント区分し、ファンコニ貧血薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ファンコニ貧血薬の世界市場概要 ・ファンコニ貧血薬の製造コスト構成分析 ・ファンコニ貧血薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ファンコニ貧血薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ファンコニ貧血薬のセグメント分析（種類別） （エルトロンボパグオラミン、EXG-34217、ファンカレン、その他）...The global Fanconi Anemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Fanconi Anemia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fanconi Anemia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Fanconi Anemia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の退形成性乏突起膠腫薬市場 2019年
    DATA909X03539 / QYResearch / 2019年11月15日 / ※本調査レポートは、退形成性乏突起膠腫薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CDX-1401、デパツキシズマブマフォドチン、フルシトシン、その他に、用途別には、病院、クリニック、研究センターにセグメント区分し、退形成性乏突起膠腫薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・退形成性乏突起膠腫薬の世界市場概要 ・退形成性乏突起膠腫薬の製造コスト構成分析 ・退形成性乏突起膠腫薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・退形成性乏突起膠腫薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・退形成性乏突起膠腫薬のセグメント分析（種類別） （CDX-1401、デパツキシズマブマフォドチン、フルシトシン、その他）...The global Anaplastic Oligoastrocytoma Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anaplastic Oligoastrocytoma Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anaplastic Oligoastrocytoma Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Anaplastic Oligoastrocytoma Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の緑膿菌肺炎治療薬市場 2019年
    DATA909X13859 / QYResearch / 2019年11月20日 / ※本調査レポートは、緑膿菌肺炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アエルシン、EV-035、MEDI-3902、パノバクマブ、その他に、用途別には、病院、クリニック、その他にセグメント区分し、緑膿菌肺炎治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・緑膿菌肺炎治療薬の世界市場概要 ・緑膿菌肺炎治療薬の製造コスト構成分析 ・緑膿菌肺炎治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・緑膿菌肺炎治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・緑膿菌肺炎治療薬のセグメント分析（種類別） （アエルシン、EV-035、MEDI-3902、パノバクマブ、その他）...The global Pseudomonas Aeruginosa Pneumonia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pseudomonas Aeruginosa Pneumonia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pseudomonas Aeruginosa Pneumonia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pseudomonas Aeruginosa Pneumonia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆